| 摘要 |
Provided is an HIV-1 integrase inhibitor, comprising an anchor RNA designed according to a sequence segment of an HIV-1 long terminal repeat sequence, in which the anchor RNA is combined with podophyllotoxin derivatives etopophos and teniposide. The integrase inhibitor increases a specificity of the drug for killing an HIV-1 virus, and reduces the damage of the drug on other normal cells. |
